FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 19756148 · Received July 16, 2024

Report

Report Number
1823260-2024-02055
Event Type
Malfunction
Date Received
July 16, 2024
Date of Event
June 19, 2024
Report Date
September 27, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

E1 INITIAL REPORTER FACILITY NAME: (B)(6). THE REAGENT LOT NUMBER IS 801069. THE EXPIRATION DATE WAS NOT PROVIDED. IT WAS NOTED THAT THE SAMPLE PROBE WAS DIRTY AND SERUM WAS ON THE SAMPLE PROBE PATH. THE FIELD SERVICE REPRESENTATIVE CHANGED THE SAMPLE PROBE AND ADJUSTED IT. HE ADJUSTED THE CELL RINSE STATION'S LEVELS AND ADJUSTED THE REAGENT CAP PIERCER. THE INVESTIGATION WAS ONGOING.

Additional Manufacturer Narrative · 0

AFTER SERVICE, NO ISSUES WERE REPORTED BY THE CUSTOMER. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE CREATININE RESULTS FOR 3 PATIENT SAMPLES ON A COBAS C 503 ANALYTICAL UNIT. PATIENT 1 (ID: (B)(6): THE INITIAL RESULT WAS 461 MOL. THE REPEATED RESULT WAS 52 MOL/L. PATIENT 2 (ID: (B)(6): THE INITIAL RESULT WAS 285 MOL/L. THE REPEATED RESULT WAS 75 MOL/L. PATIENT 3 (ID: (B)(6): THE INITIAL RESULT WAS 394 MOL/L. THE REPEATED RESULT WAS 95.6 MOL/L. THE SAMPLES WERE REPEATED DUE TO THE INITIAL RESULTS NOT MATCHING THE PATIENTS' CLINICAL HISTORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2509347 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown